Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OK-432 Pleurodesis for Postoperative Air Leak
NCT02502643Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Jul 2015
- Primary completion
- Jul 2018
- Modality
- Small Molecules, Cell Therapies, Therapeutic Vaccines
- Countries
- 1
01
Overview
Randomised, open-label trial of streptococcus pyogenes preparation in air leak syndrome (ALS) (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: OK-432 success rate at 48 hours. Status: unknown.
02
Drugs
streptococcus pyogenes preparation
03
Conditions
air leak syndrome (ALS)
Beyond the preview
Go deeper on NCT02502643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02502643.